Aortic stenosis (AS) is the most frequent valvular pathology and is one of the most common indications of valve replacement surgery. Its main form of presentation is calcified AS, whose prevalence increases proportionally with age. The indication of aortic valve replacement (AVR) is clear when the echocardiographic parameters of severity are coincident with each other and the patient presents symptoms, deterioration of the left ventricular ejection fraction (LVEF) or other indication of cardiac surgery. But with the advancement of diagnostic methods, new classifications of this condition have emerged. The term "paradoxical low-flow, low-gradient aortic stenosis" appears, which refers to the presence of an aortic valve area (AVA) <1 cm 2 or indexed AVA <0.6 cm 2 /m 2 , associated with low transvalvular flow and gradients, but with preserved LVEF (≥50%). This combination of data leads to a discordant classification (AVA in range of severity, medium gradient with values of mild to moderate disease). Due to the probability of potential errors that could underestimate the AVA by Doppler echo, and the uncertainty about the real meaning of this pathology, it is necessary to confirm the veracity of these findings, to give a correct diagnosis and treatment to patients with this intriguing entity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.